Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 69 results.
User Information
Export Records
  1. 1.   An Agrin-YAP/TAZ Rigidity Sensing Module Drives EGFR-Addicted Lung Tumorigenesis
  2. Mokhtari, Reza Bayat; Sampath, Divyaleka; Eversole, Paige; Yu Lin, Melissa Ong; Bosykh, Dmitriy A; Boopathy, Gandhi T K; Sivakumar, Aravind; Wang, Cheng-Chun; Kumar, Ramesh; Sheng, Joe Yeong Poh; Karasik, Ellen; Foster, Barbara A; Yu, Han; Ling, Xiang; Wu, Wenjie; Li, Fengzhi; Ohler,Zoe; Brainson, Christine F; Goodrich, David W; Hong, Wanjin; Chakraborty, Sayan
  3. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 2025, Mar 31; e2413443.
  1. 2.   Epigenetic associations with kidney disease in individuals of African ancestry with APOL1 high-risk genotypes and Human Immunodeficiency Virus
  2. Hung, Rachel K Y; Costeira, Ricardo; Chen, Junyu; Schlosser, Pascal; Grundner-Culemann, Franziska; Booth, John W; Sharpe, Claire C; Bramham, Kate; Sun, Yan V; Marconi, Vincent C; Teumer, Alexander; Winkler,Cheryl; Post, Frank A; Bell, Jordana T
  3. Nephrology, Dialysis, Transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2024, Oct 24;
  1. 3.   Deoxybouvardin targets EGFR, MET, and AKT signaling to suppress non-small cell lung cancer cells
  2. Nam, A-Young; Joo, Sang Hoon; Khong,Quan; Park, Jisu; Lee, Na Yeong; Lee, Seung-On; Yoon, Goo; Park, Jin Woo; Na, MinKyun; Shim, Jung-Hyun
  3. Scientific Reports. 2024, Sep 06; 14(1): 20820.
  1. 4.   The structural basis of BCR-ABL recruitment of GRB2 in chronic myelogenous leukemia
  2. Liu,Yonglan; Jang,Hyunbum; Zhang,Mingzhen; Tsai,Chung-Jung; Maloney,Ryan; Nussinov,Ruth
  3. Biophysical Journal. 2022, May 31;
  1. 5.   APOL1 Renal Risk Variants and Kidney Function in HIV-1-Infected People From Sub-Saharan Africa
  2. Kabore, Nongodo Firmin; Cournil, Amandine; Poda, Armel; Ciaffi, Laura; Binns-Roemer,Elizabeth; David,Victor; Eymard-Duvernay, Sabrina; Zoungrana, Jacques; Semde, Aoua; Sawadogo, Adrien B; Koulla-Shiro, Sinata; Kouanfack, Charles; Ngom-Gueye, Ndeye Fatou; Meda, Nicolas; Winkler,Cheryl; Limou, Sophie
  3. Kidney International Reports. 2022, Mar; 7(3): 483-493.
  1. 6.   New Therapeutic Opportunities for the Treatment of Squamous Cell Carcinomas: A Focus on Novel Driver Kinases
  2. Bensen, Ryan; Brognard,John
  3. International Journal of Molecular Sciences. 2021, Mar; 22(6):
  1. 7.   C-CBL is required for inhibition of angiogenesis through modulating JAK2/STAT3 activity in ROP development
  2. Chen, Shimei; Sun, Qiao; Sun, Dandan; Willette Brown,Jami; Anderson,Matthew; Gu, Qing; Lewandoski,Mark; Hu, Yinling; Zhu,Feng; Wei, Fang; Zhang, Jian
  3. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. 2020, DEC; 132: 110856.
  1. 8.   Significance of pro-angiogenic estrogen metabolites in normal follicular development and follicular growth arrest in polycystic ovary syndrome
  2. Henríquez, Soledad; Kohen, Paulina; Xu,Xia; Villarroel, Claudio; Muñoz, Alex; Godoy, Ana; Strauss, Jerome F; Devoto, Luigi
  3. Human reproduction (Oxford, England). 2020, JUL; 35(7): 1655-1665.
  1. 9.   Bacterial Phytochrome as a Scaffold for Engineering of Receptor Tyrosine Kinases Controlled with Near-Infrared Light
  2. Leopold, Anna; Pletnev,Sergei; Verkhusha, Vladislav V.
  3. JOURNAL OF MOLECULAR BIOLOGY. 2020, JUN 12; 432(13): 3749-3760.
  1. 10.   Vav1 is Essential for HIF-1a Activation via a Lysosomal VEGFR1-Mediated Degradation Mechanism in Endothelial Cells
  2. Hong,Jaewoo; Min,Yongfen; Wuest, Todd; Lin,Charles
  3. Cancers. 2020, JUN; 12(6): E1374.
  1. 11.   Oxygen Tension Regulates Lysosomal Activation and Receptor Tyrosine Kinase Degradation
  2. Hong,Jaewoo; Wuest, Todd R; Min,Yongfen; Lin,Charles
  3. Cancers. 2019, Nov; 11(11): pii: E1653..
  1. 12.   KRAS G13D sensitivity to neurofibromin-mediated GTP hydrolysis
  2. Rabara,Dana; Tran,Tim; Dharmaiah,Sathiya; Stephens,Bob; McCormick, Frank; Simanshu,Dhirendra; Holderfield, Matthew
  3. Proceedings of the National Academy of Sciences of the United States of America. 2019, OCT 29; 116(44): 22122-22131.
  1. 13.   Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer
  2. Ma, Lichun; Hernandez,Maria; Zhao,Yongmei; Mehta,Monika; Tran,Bao; Kelly,Michael; Rae,Zachary; Hernandez, Jonathan M; Davis, Jeremy L; Martin, Sean P; Kleiner, David E; Hewitt, Stephen M; Ylaya, Kris; Wood, Bradford J; Greten, Tim F; Wang, Xin Wei
  3. Cancer cell. 2019, Oct 14; 36(4): 418-430.
  1. 14.   Development and interlaboratory evaluation of a NIST Reference Material RM 8366 for EGFR and MET gene copy number measurements
  2. He, Hua-Jun; Das,Biswajit; Cleveland, Megan H; Chen,Li; Camalier,Corinne; Liu, Liang-Chun; Norman, Kara L; Fellowes, Andrew P; McEvoy, Christopher R; Lund, Steve P; Almeida, Jamie; Steffen, Carolyn R; Karlovich,Chris; Williams,Mickey; Cole, Kenneth D
  3. Clinical chemistry and laboratory medicine. 2019, Aug; 57(8): 1142-1152.
  1. 15.   A phase I study of the PD-L1 inhibitor, durvalumab, in combination with a PARP inhibitor, olaparib, and a VEGFR1-3 inhibitor, cediranib, in recurrent women's cancers with biomarker analyses
  2. Zimmer, Alexandra S; Nichols,Erin; Cimino-Mathews, Ashley; Peer, Cody; Cao, Liang; Lee, Min-Jung; Kohn, Elise C; Annunziata, Christina M; Lipkowitz, Stanley; Trepel, Jane B; Sharma, Rajni; Mikkilineni, Lekha; Gatti-Mays, Margaret; Figg, William D; Houston, Nicole D; Lee, Jung-Min
  3. Journal for immunotherapy of cancer. 2019, Jul 25; 7(1): 197.
  1. 16.   Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health
  2. Cheng, Feixiong; Liang, Han; Butte, Atul J.; Eng, Charis; Nussinov, Ruth
  3. Pharmacological reviews. 2019, Jan; 71(1): 1-19.
  1. 17.   Cell-Free DNA Next-Generation Sequencing Prediction of Response and Resistance to Third-Generation EGFR Inhibitor
  2. Helman, Elena; Nguyen, Minh; Karlovich, Chris; Despain, Darrin; Choquette, A Karin; Spira, Alexander I; Yu, Helena A; Camidge, D Ross; Harding, Thomas C; Lanman, Richard B; Simmons, Andrew D
  3. Clinical lung cancer. 2018, Nov; 19(6): 518-530.e7.
  1. 18.   Protein Synthesis Inhibition Activity of Mesothelin Targeting Immunotoxin LMB-100 Decreases Concentrations of Oncogenic Signaling Molecules and Secreted Growth Factors
  2. El-Behaedi, Salma; Landsman, Rebekah; Rudloff, Michael; Kolyvas, Emily; Albalawy, Rakan; Zhang, Xianyu; Bera, Tapan; Collins, Keith; Kozlov, Serguei; Alewine, Christine
  3. Toxins. 2018, Nov; 10(11): pii: E447.
  1. 19.   Metformin sensitizes lung cancer cells to treatment by the tyrosine kinase inhibitor erlotinib
  2. Wang, Xiaofei; Chen, Keqiang; Yu, Ying; Xiang, Yi; Kim, Jae Hong; Gong, Wang; Huang, Jiaqiang; Shi, Guochao; Li, Qingyun; Zhou, Min; Sayers, Thomas; Tewary, Poonam; Gao, Beili; Wang, Jiming
  3. Oncotarget. 2017, Dec 12; 8(65): 109068-109078.
  1. 20.   Autophagy-induced KDR/VEGFR-2 activation promotes the formation of vasculogenic mimicry by glioma stem cells
  2. Wu, Hai-Bo; Yang, Shuai; Weng, Hai-Yan; Chen, Qian; Zhao, Xi-Long; Fu, Wen-Juan; Niu, Qin; Ping, Yi-Fang; Wang, Jiming; Zhang, Xia; Yao, Xiao-Hong; Bian, Xiu-Wu
  3. Autophagy. 2017, Sep 2; 13(9): 1528-1542.
  1. 21.   C/EBP-d positively regulates MDSC expansion and endothelial VEGFR2 expression in tumor development
  2. Min, Yongfen; Li, Jingdong; Qu, Peng; Lin, Charles
  3. Oncotarget. 2017, Aug 1; 8(31): 50582-50593.
  1. 22.   Autoreactive T Cells and Chronic Fungal Infection Drive Esophageal Carcinogenesis
  2. Zhu, Feng; Willette Brown, Jami; Song, Na-Young; Lomada, Dakshayani; Song, Yongmei; Xue, Liyan; Gray, Zane; Zhao, Zitong; Davis, Sean R; Sun, David; Zhang, Peilin; Wu, Xiaolin; Zhan, Qimin; Richie, Ellen R; Hu, Yinling
  3. Cell Host & Microbe. 2017, Apr 12; 21(4): 478-493.e7.
  1. 23.   Endothelin causes transactivation of the EGFR and HER2 in non-small cell lung cancer cells
  2. Moody, Terry W.; Ramos-Alvarez, Irene; Moreno, Paula; Mantey, Samuel A.; Ridnour, Lisa; Wink, David; Jensen, Robert T.
  3. PEPTIDES. 2017, Apr; 90: 90-99.
  1. 24.   TEM8/ANTXR1 Blockade Inhibits Pathological Angiogenesis and Potentiates Tumoricidal Responses against Multiple Cancer Types
  2. Chaudhary, A.; Hilton, M. B.; Seaman, S.; Haines, D. C.; Stevenson, S.; Lemotte, P. K.; Tschantz, W. R.; Zhang, X. Y. M.; Saha, S.; Fleming, T.; St Croix, B.
  3. Cancer Cell. 2012, Feb; 21(2): 212-226.
  1. 25.   Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296
  2. Langenkamp, E.; Zwiers, P. J.; Moorlag, H. E.; Leenders, W. P.; Croix, B. S.; Molema, G.
  3. Anti-Cancer Drugs. 2012, Feb; 23(2): 161-172.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel